During the past decade, Hospital Nacional Dos de Mayo conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nacional Dos de Mayo" #1 sponsor was "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials, followed by "PhotoThera, Inc" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Dos de Mayo" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "London School of Hygiene and Tropical Medicine" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator, "Northwestern University" with 1 trials as a collaborator and "University of Botswana" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Dos de Mayo" are "HIV Infections" (2 trials), "Acute Ischemic Stroke" (1 trials), "COVID-19 Pneumonia" (1 trials), "Colorectal Cancer" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Hospital Nacional Dos de Mayo" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Dos de Mayo" are "Drug" (10 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "NeuroThera® Laser System" (2 trials), "Placebo" (2 trials), "APL-2" (1 trials), "Amphotericin B" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Dos de Mayo" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Nacional Dos de Mayo". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Nacional Dos de Mayo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Dos de Mayo, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".